Black Diamond Therapeutics, Inc. · NASDAQ:BDTX
Behbahani Ali received 7,707 Black Diamond Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 18, 2026 · Filed Sep 21, 2026
On Sep 18, 2026, Behbahani Ali (Director) received 7,707 Black Diamond Therapeutics, Inc. shares as an award at US$1.93 for US$14,875, leaving 110,236 shares. Filed Sep 21, 2026 (Form 4).
- Awarded
- 7,707 shares
- Price
- US$1.93
- Value
- US$14,875
- Holding after
- 110,236 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | Award | 7,707 | US$1.93 | 110,236 | Direct |
Source
Related
- Black Diamond Therapeutics, Inc.
- Behbahani Ali
- Black Diamond Therapeutics, Inc. shareholders
- Form 4 · Behbahani Ali · Jun 22, 2026
- Form 4 · Raman Prakash · Sep 21, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Jul 8, 2026
- Form 4 · Raman Prakash · Jun 22, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Feb 17, 2026